Investing in Glaukos three years ago would have delivered you a 174 percent gain
| GKOS Stock | USD 156.53 1.59 1.01% |
Slightly above 62% of Glaukos Corp's investor base is looking to short. The analysis of overall sentiment of trading Glaukos Corp stock suggests that many investors are alarmed at this time. Glaukos Corp's investing sentiment can be driven by a variety of factors including economic data, Glaukos Corp's earnings reports, geopolitical events, and overall market trends.
Glaukos |
The most you can lose on any stock is 100 percent of your money. But in contrast you can...
Read at simplywall.st
 |
Glaukos Corp Fundamental Analysis
We analyze Glaukos Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Glaukos Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Glaukos Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Glaukos Corp is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Glaukos Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Glaukos Corp stock to make a market-neutral strategy. Peer analysis of Glaukos Corp could also be used in its relative valuation, which is a method of valuing Glaukos Corp by comparing valuation metrics with similar companies.
Peers
Glaukos Corp Related Equities
| KIDS | Orthopediatrics Corp | 1.12 | ||||
| ITGR | Integer Holdings | 0.46 | ||||
| CNMD | CONMED | 0.09 | ||||
| BRKR | Bruker | 0.28 | ||||
| OFIX | Orthofix Medical | 0.76 | ||||
| SRDX | SurModics | 1.44 | ||||
| SGHT | Sight Sciences | 2.11 | ||||
| IRMD | Iradimed | 2.78 | ||||
| LIVN | LivaNova PLC | 2.87 | ||||
| FNA | Paragon 28 | 3.54 | ||||
| NVRO | Nevro Corp | 5.73 |
Additional Tools for Glaukos Stock Analysis
When running Glaukos Corp's price analysis, check to measure Glaukos Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaukos Corp is operating at the current time. Most of Glaukos Corp's value examination focuses on studying past and present price action to predict the probability of Glaukos Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glaukos Corp's price. Additionally, you may evaluate how the addition of Glaukos Corp to your portfolios can decrease your overall portfolio volatility.